2017 2021 2020 2019 2018 All years December 15, 2017 XNK Therapeutics receives orphan drug designation from EMA For more info: https://news.cision.com/se/xnk-therapeutics-ab/r/svenska-cellterapikandidaten-cellprotect-har-erhallit-sarlakemedelsstatus-for-behandling-av-multipel,c2415694 January 31, 2017 XNK Therapeutics granted US patent for method to treat MM with NK cells XNK Therapeutics AB (“XNK”) announced today it received a patent from the US for its method of treating multiple myeloma with expanded NK cells. “Being granted this patent in the US is an…
December 15, 2017 XNK Therapeutics receives orphan drug designation from EMA For more info: https://news.cision.com/se/xnk-therapeutics-ab/r/svenska-cellterapikandidaten-cellprotect-har-erhallit-sarlakemedelsstatus-for-behandling-av-multipel,c2415694
January 31, 2017 XNK Therapeutics granted US patent for method to treat MM with NK cells XNK Therapeutics AB (“XNK”) announced today it received a patent from the US for its method of treating multiple myeloma with expanded NK cells. “Being granted this patent in the US is an…
